» Articles » PMID: 3138408

Reciprocal Modulation of Agonist and Antagonist Binding to A1 Adenosine Receptors by Guanine Nucleotides is Mediated Via a Pertussis Toxin-sensitive G Protein

Overview
Specialty Pharmacology
Date 1988 Sep 1
PMID 3138408
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we have characterized the effects of guanine nucleotides on agonist and antagonist binding to A1 adenosine receptors, which mediate inhibition of adenylate cyclase via the inhibitory G protein (Gi) in adipocytes. Our data indicate that guanosine-triphosphate (GTP) and guanyl-5'-yl imidodiphosphate (Gpp(NH)p) enhance the binding of 8-(4-[(([(2-amino-ethyl)amino]carbonyl) methyl)oxyl]phenyl)-1,3-dipropylxanthine ([3H]XAC) to adipocyte membranes in a dose-dependent manner, with EC50 values being 1.8 and 2.2 microM, respectively. The stimulatory effect of GTP was abolished in pertussis toxin-intoxicated membranes, implying a role of a pertussis toxin-sensitive G protein in mediating this effect. Furthermore, the ranked order of efficacy for a series of guanine nucleotides to enhance [3H]XAC binding was GTP = Gpp(NH)p greater than GDP greater than GDP beta S = cGMP, which paralleled their ability to inhibit forskolin-stimulated adenylate cyclase activity. Saturation isotherms performed in the absence and presence of GTP and Gpp(NH)p indicate that the guanine nucleotide decreased the equilibrium dissociation constant (KD) but had no effect on the maximal binding (Bmax) of [3H]XAC. In contrast, Gpp(NH)p decreased agonist binding as manifested by a decrease in the percentage of A1 adenosine receptors in the agonist high affinity state (from 81% to 27%) without changing the high (KH) and low (KL) affinity constants. Kinetic experiments conducted to assess the effect of guanine nucleotide on [3H]XAC binding parameters demonstrate that Gpp(NH)p enhanced the observed rate of association (Kobs) of the radioligand with the receptor by 2-fold but had no effect on the rate of dissociation (K-1) of the radioligand-receptor complex.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Tonic activity of the rat adipocyte A1-adenosine receptor.

Belardinelli L, Ozeck M, Shryock J Br J Pharmacol. 2002; 135(6):1457-66.

PMID: 11906959 PMC: 1573251. DOI: 10.1038/sj.bjp.0704586.


Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

de Ligt R, Kourounakis A, IJzerman A Br J Pharmacol. 2000; 130(1):1-12.

PMID: 10780991 PMC: 1572052. DOI: 10.1038/sj.bjp.0703311.


Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.

Zocchi C, Ongini E, Ferrara S, Baraldi P, Dionisotti S Br J Pharmacol. 1996; 117(7):1381-6.

PMID: 8730729 PMC: 1909468. DOI: 10.1111/j.1476-5381.1996.tb15296.x.


Functional coupling between A1 adenosine receptors and G-proteins in rat hippocampal membranes assessed by high-affinity GTPase activity.

Odagaki Y, Fuxe K Br J Pharmacol. 1995; 116(6):2691-7.

PMID: 8590991 PMC: 1909133. DOI: 10.1111/j.1476-5381.1995.tb17228.x.


Agonist-independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells.

Hanf R, Li Y, Szabo G, Fischmeister R J Physiol. 1993; 461:743-65.

PMID: 8350280 PMC: 1175283. DOI: 10.1113/jphysiol.1993.sp019539.